Literature DB >> 6601617

Modulation of human mononuclear cell responses by neutrophil-derived factors. II. Partial characterization of a neutrophil-derived lymphocyte-enhancing factor (N-LEF).

R S Panush.   

Abstract

We previously reported that neutrophil (PMN)-derived factors modulated human mononuclear cell (MNC) responses. These interactions are important in understanding MNC localization, growth, and activation in inflammatory events such as occur in the rheumatoid synovium. We have partially identified and characterized a human neutrophil-derived, lymphocyte-enhancing factor (N-LEF). Highly purified PMN, devoid of MNC or platelets, were obtained by density gradient sedimentation. Supernatants (spt) were prepared from PMN phagocytosis of complement-coated zymosan particles. N-LEF was determined by [3H]TdR uptake or Ig secretion by stimulated MNC of cell lines. Neutral protease activity was quantitated by digestion of 125I-labeled Hb. Sodium dodecylsulfate (SDS) polyacrylamide gel electropheresis (PAGE) was carried out in 15% gels. We found (1) N-LEF biologic activity was cold stable, heat labile, nondialyzable, and diminished at acid pH (less than 4) or alkaline pH (greater than 10); (2) N-LEF biologic activity was abrogated by human plasma; (3) spt contained neutral protease and granule-associated but not cytoplasmic enzyme activities; (4) protease activities (for Hb, fibrin, ATEE, and Ac-Phe-BNa) were recovered from aprotinin-sepharose affinity columns and contained approximately 25,000 and approximately 28,000 molecular weight material on SDS-PAGE; (5) absorbtion of N-LEF spt on aprotinin-sepharose diminished both protease and biologic activities; and (6) N-LEF biologic activity and nonelastase neutral protease activity were found in approximately 13,000 mol wt fractions of Sephadex G100 (where cathepsin G chromatographs). Our observations suggest that phagocytosis of immune complexes by PMN induces release of a mononuclear cell enhancing factor, N-LEF, which may be an important mediator of inflammation, promoting transition from an acute to a chronic inflammatory response. Biologic properties of N-LEF are those of cathepsin G.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6601617     DOI: 10.1007/BF00918006

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  38 in total

1.  Interaction between lymphocytes and inflammatory exudate cells. II. A proteolytic enzyme released by PMN as a possible mediator for enhancement of thymocyte response.

Authors:  S Nakamura; M Yoshinaga; H Hayashi
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

2.  Interaction between lymphocytes and inflammatory exudate cells. I. Enhacement of thymocyte response to PHA by product(s) of polymorphonuclear leukocytes and macrophages.

Authors:  M Yoshinaga; S Nakamura; H Hayashi
Journal:  J Immunol       Date:  1975-08       Impact factor: 5.422

3.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

4.  Cationic proteins from human neutrophil granulocytes. Evidence for their chymotrypsin-like properties.

Authors:  R Rindler-Ludwig; H Braunsteiner
Journal:  Biochim Biophys Acta       Date:  1975-02-27

Review 5.  The immunopathology of joint inflammation in rheumatoid arthritis.

Authors:  N J Zvaifler
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

6.  A new lymphocyte transforming factor derived from the lysosomes of polymorphonuclear leucocytes.

Authors:  H Tchórzewski; Z Sulowska; A Denys
Journal:  Experientia       Date:  1973-04-15

7.  Purification to apparent homogeneity of murine interleukin 1.

Authors:  S B Mizel; D Mizel
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

Review 8.  Immune-complex-mediated biologic effects.

Authors:  R C Wiggins; C G Cochrane
Journal:  N Engl J Med       Date:  1981-02-26       Impact factor: 91.245

9.  Antigammaglobulins in normal individuals and in patients with adult and juvenile rheumatoid arthritis and osteoarthritis.

Authors:  P H Schur; N E Bianco; R S Panush
Journal:  Rheumatology       Date:  1975       Impact factor: 7.580

10.  Human serum beta-glucuronidase; its measurement and some of its properties.

Authors:  W H Fishman; K Kato; C L Anstiss; S Green
Journal:  Clin Chim Acta       Date:  1967-03       Impact factor: 3.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.